Synergistic Antitumor Activity of Sorafenib in Combination With Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-10-0923

Related search